Medical Consent Concerns

A shift in the approach to transgender health has led to an informed consent model, allowing individuals as young as 15 to access hormone treatments without parental approval. This raises critical questions about the implications of such autonomy at a young age, particularly regarding the decision-making process typically reserved for medical professionals. The discussion highlights the complexities surrounding identity, medical intervention, and the societal responsibilities tied to these choices.